Previous close | 533.35 |
Open | 533.65 |
Bid | 533.20 x 800 |
Ask | 0.00 x 800 |
Day's range | 533.65 - 539.38 |
52-week range | 412.00 - 542.07 |
Volume | |
Avg. volume | 963,214 |
Market cap | 125.176B |
Beta (5Y monthly) | 0.79 |
PE ratio (TTM) | 20.32 |
EPS (TTM) | 26.50 |
Earnings date | 17 Jul 2024 - 22 Jul 2024 |
Forward dividend & yield | 6.52 (1.21%) |
Ex-dividend date | 10 Jun 2024 |
1y target est | 605.45 |
Most readers would already know that Elevance Health's (NYSE:ELV) stock increased by 6.4% over the past three months...
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
Believes Enhabit’s Shares Do Not Reflect its Intrinsic Value or Strategic Potential Has Nominated Seven Highly Qualified Independent Directors Believes AREX Slate Would Provide Board With Sorely Needed Home Health and Hospice Expertise NEW YORK, May 09, 2024 (GLOBE NEWSWIRE) -- AREX Capital Management, LP (“AREX Capital Management” or “we”), together with its affiliates, the owners of approximately 4.8% of the shares of Enhabit, Inc. (NYSE: EHAB) (the “Company” or “Enhabit”), today issued the be